Rolinsatamab - CAS 2095467-30-2

Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.

ADC Antibody, IL Receptor

Immunology/Inflammation, Antibody-drug Conjugate/ADC Related

2095435

>95%

-20°C

Ice Packs

Inhibitory Antibodies